Timothy J. Panella

High-Dose Oral Tamoxifen, a Potential Multidrug-Resistance-Reversal Agent: Phase I Trial in Combination With Vinblastine

D L Trump, David C. Smith, Peter Ellis et al. · JNCI Journal of the National Cancer Institute · 1992 · 212 citations

Medicine, Oncology, Pharmacology +11

Prognostic Value of Breast Cancer Subtypes, Ki-67 Proliferation Index, Age, and Pathologic Tumor Characteristics on Breast Cancer Survival in Caucasian Women

N. Lynn Ferguson, John L. Bell, R. Eric Heidel et al. · The Breast Journal · 2012 · 87 citations

Medicine, Oncology, Breast Oncology +13

Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells

Ronna E. Dornsife, M H St Clair, A T Huang et al. · Antimicrobial Agents and Chemotherapy · 1991 · 80 citations · Full text

Medicine, Hematology, Pharmacology +16

Is the TNM Staging System for Breast Cancer Still Relevant in the Era of Biomarkers and Emerging Personalized Medicine for Breast Cancer - An Institution's 10-year Experience

Amila Orucevic, Jason Chen, James M. McLoughlin et al. · The Breast Journal · 2015 · 39 citations

Medicine, Oncology, Breast Oncology +15

Platelets acquire a secretion defect after high-dose chemotherapy

Timothy J. Panella, William P. Peters, James G. White et al. · Cancer · 1990 · 30 citations · Full text

Medicine, Hematology, Pharmacology +17